news article details

MLN Connects® Newsletter: Broader Medicare Coverage of Leqembi Available Following FDA Traditional Approval - July 7, 2023


Broader Medicare coverage is now available for Biogen and Eisai’s Leqembi (the brand name for lecanemab) following the FDA's move to grant traditional approval to the drug that treats individuals with Alzheimer’s disease. The CMS had previously announced this would be the case and released more details on coverage.

Posted 7/7/2023